Sign in

CIK 0001798749

  • Emerging growth company

Jade Biosciences, Inc.

Sign in to watch
Ticker
JBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831377888
Phone
+1 781-312-3013
Business address
221 CRESCENT ST., BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aerovate Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 84 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-03-07 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −945 15,324
2024-03-07 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −8,030 101,510
2024-03-04 Dable Habib J Director Grant or award · Stock Option (Right to Buy) +1,531 $16.37 $25K 1,531
2024-02-23 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise 10b5-1 +511 $1.74 $889 3,762
2024-02-23 Gillies Hunter CHIEF MEDICAL OFFICER Sale 10b5-1 −511 $19.50 $10K 3,251
2024-02-23 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −511 3,014
2024-02-20 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise 10b5-1 +3,489 $1.74 $6K 6,740
2024-02-20 Gillies Hunter CHIEF MEDICAL OFFICER Sale 10b5-1 −2,591 $20.11 $52K 4,149
2024-02-20 Gillies Hunter CHIEF MEDICAL OFFICER Sale 10b5-1 −898 $20.58 $18K 3,251
2024-02-20 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −2,502 3,525
2024-02-20 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −987 8,036
2024-02-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise 10b5-1 +1,400 $1.74 $2K 3,009
2024-02-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise 10b5-1 +3,200 $2.14 $7K 6,209
2024-02-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Sale 10b5-1 −4,600 $17.45 $80K 1,609
2024-02-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −900 13,308
2024-02-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −500 9,088
2024-02-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −500 10,894
2024-02-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −1,200 34,908
2024-02-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −1,500 41,732
2024-01-29 NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Grant or award · Stock Option (Right to Buy) +200,000 200,000

Page 8 of 16 · 315 trades